Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Noriko Kishida"'
Autor:
Amanda C Perofsky, John Huddleston, Chelsea L Hansen, John R Barnes, Thomas Rowe, Xiyan Xu, Rebecca Kondor, David E Wentworth, Nicola Lewis, Lynne Whittaker, Burcu Ermetal, Ruth Harvey, Monica Galiano, Rodney Stuart Daniels, John W McCauley, Seiichiro Fujisaki, Kazuya Nakamura, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa, Sheena G Sullivan, Ian G Barr, Kanta Subbarao, Florian Krammer, Trevor Bedford, Cécile Viboud
Publikováno v:
eLife, Vol 13 (2024)
Influenza viruses continually evolve new antigenic variants, through mutations in epitopes of their major surface proteins, hemagglutinin (HA) and neuraminidase (NA). Antigenic drift potentiates the reinfection of previously infected individuals, but
Externí odkaz:
https://doaj.org/article/d48411453a434048a41f9bcc8eba52b3
Autor:
Sho Miyamoto, Yudai Kuroda, Takayuki Kanno, Akira Ueno, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, Yusuke Sakai, Noriyo Nagata, Takeshi Arashiro, Akira Ainai, Saya Moriyama, Noriko Kishida, Shinji Watanabe, Kiyoko Nojima, Yohei Seki, Takuo Mizukami, Hideki Hasegawa, Hideki Ebihara, Shuetsu Fukushi, Yoshimasa Takahashi, Ken Maeda, Tadaki Suzuki
Publikováno v:
iScience, Vol 26, Iss 5, Pp 106694- (2023)
Summary: Evaluating the serum cross-neutralization responses after breakthrough infection with various SARS-CoV-2 variants provides valuable insight for developing variant-proof COVID-19 booster vaccines. However, fairly comparing the impact of break
Externí odkaz:
https://doaj.org/article/67f878daf29d4a9d93a13104fc46ab22
Autor:
Joanna Waldock, Carol D. Weiss, Wei Wang, Min Z. Levine, Stacie N. Jefferson, Sammy Ho, Katja Hoschler, Brandon Z. Londt, Elisa Masat, Louise Carolan, Stephany Sánchez-Ovando, Annette Fox, Shinji Watanabe, Miki Akimoto, Aya Sato, Noriko Kishida, Amelia Buys, Lorens Maake, Cardia Fourie, Catherine Caillet, Sandrine Raynaud, Richard J. Webby, Jennifer DeBeauchamp, Rebecca J. Cox, Sarah L. Lartey, Claudia M. Trombetta, Serena Marchi, Emanuele Montomoli, Iván Sanz-Muñoz, José María Eiros, Javier Sánchez-Martínez, Danny Duijsings, Othmar G. Engelhardt
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionExternal Quality Assessment (EQA) schemes are designed to provide a snapshot of laboratory proficiency, identifying issues and providing feedback to improve laboratory performance and inter-laboratory agreement in testing. Currently there
Externí odkaz:
https://doaj.org/article/336faf037fe6487d9afa1b75516f9b2d
Autor:
Perofsky, Amanda C., Huddleston, John, Hansen, Chelsea L., Barnes, John R., Rowe, Thomas, Xiyan Xu, Kondor, Rebecca, Wentworth, David E., Lewis, Nicola, Whittaker, Lynne, Ermetal, Burcu, Harvey, Ruth, Galiano, Monica, Daniels, Rodney Stuart, McCauley, John W., Seiichiro Fujisaki, Kazuya Nakamura, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa
Publikováno v:
eLife; 9/25/2024, p1-50, 50p
Autor:
Emi Takashita, Masataka Ichikawa, Hiroko Morita, Rie Ogawa, Seiichiro Fujisaki, Masayuki Shirakura, Hideka Miura, Kazuya Nakamura, Noriko Kishida, Tomoko Kuwahara, Hiromi Sugawara, Aya Sato, Miki Akimoto, Keiko Mitamura, Takashi Abe, Masahiko Yamazaki, Shinji Watanabe, Hideki Hasegawa, Takato Odagiri
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 11, Pp 2108-2111 (2019)
In 2019, influenza A(H3N2) viruses carrying an I38T substitution in the polymerase acidic gene, which confers reduced susceptibility to baloxavir, were detected in Japan in an infant without baloxavir exposure and a baloxavir-treated sibling. These v
Externí odkaz:
https://doaj.org/article/e4da5547b44246bb9672e7a74922ee58
Autor:
John Huddleston, John R Barnes, Thomas Rowe, Xiyan Xu, Rebecca Kondor, David E Wentworth, Lynne Whittaker, Burcu Ermetal, Rodney Stuart Daniels, John W McCauley, Seiichiro Fujisaki, Kazuya Nakamura, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa, Ian Barr, Kanta Subbarao, Pierre Barrat-Charlaix, Richard A Neher, Trevor Bedford
Publikováno v:
eLife, Vol 9 (2020)
Seasonal influenza virus A/H3N2 is a major cause of death globally. Vaccination remains the most effective preventative. Rapid mutation of hemagglutinin allows viruses to escape adaptive immunity. This antigenic drift necessitates regular vaccine upd
Externí odkaz:
https://doaj.org/article/69ca1ce852c14a939cbc3f9ddb6b5815
Autor:
Emi, Takashita, Hiroko, Morita, Shiho, Nagata, Masayuki, Shirakura, Seiichiro, Fujisaki, Hideka, Miura, Ikuyo, Takayama, Tomoko, Arita, Yasushi, Suzuki, Masaoki, Yamaoka, Taichiro, Tanikawa, Ryota, Tsunekuni, Junki, Mine, Saki, Sakuma, Yuko, Uchida, Akihiro, Shibata, Mari, Iwanaka, Noriko, Kishida, Kazuya, Nakamura, Tsutomu, Kageyama, Shinji, Watanabe, Hideki, Hasegawa
Publikováno v:
Japanese Journal of Infectious Diseases. 75:398-402
The circulation of avian influenza A viruses in poultry is a public health concern due to the potential transmissibility and severity of these viral infections. Monitoring the susceptibility of these viruses to antivirals is important for developing
Autor:
Masayuki Hashimoto, Noriyo Nagata, Tomoyuki Homma, Hiroki Maeda, Keiji Dohi, Naomi M. Seki, Ken Yoshihara, Naoko Iwata-Yoshikawa, Nozomi Shiwa-Sudo, Yusuke Sakai, Masayuki Shirakura, Noriko Kishida, Tomoko Arita, Yasushi Suzuki, Shinji Watanabe, Hideki Asanuma, Takuhiro Sonoyama, Tadaki Suzuki, Shinya Omoto, Hideki Hasegawa
Publikováno v:
Vaccine. 40:4231-4241
The vaccine S-268019-b is a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S)-protein vaccine consisting of full-length recombinant SARS-CoV-2 S-protein (S-910823) as antigen, mixed with the squalene-based adjuvant A-910823. The
Autor:
Emi Takashita, Hiroko Morita, Rie Ogawa, Kazuya Nakamura, Seiichiro Fujisaki, Masayuki Shirakura, Tomoko Kuwahara, Noriko Kishida, Shinji Watanabe, Takato Odagiri
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
The novel cap-dependent endonuclease inhibitor baloxavir marboxil was approved for the treatment of influenza A and B virus infections in February 2018 in Japan. Because of the need to monitor influenza viruses for reduced susceptibility to this drug
Externí odkaz:
https://doaj.org/article/16702a9e809047f49a5b36e682ec1592
Autor:
Sho Miyamoto, Yudai Kuroda, Takayuki Kanno, Akira Ueno, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, Yusuke Sakai, Noriyo Nagata, Takeshi Arashiro, Akira Ainai, Saya Moriyama, Noriko Kishida, Shinji Watanabe, Kiyoko Nojima, Yohei Seki, Takuo Mizukami, Hideki Hasegawa, Hideki Ebihara, Shuetsu Fukushi, Yoshimasa Takahashi, Ken Maeda, Tadaki Suzuki
Understanding the differences in serum cross-neutralizing responses against SARS-CoV-2 variants, including Omicron sub-lineages BA.5, BA.2.75, and BQ.1.1, elicited by exposure to distinct antigens is essential for developing COVID-19 booster vaccines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fbaf72a165adb53fb3cbbe77bcb5a1b
https://doi.org/10.1101/2023.02.08.23285673
https://doi.org/10.1101/2023.02.08.23285673